(Price :$3500) The report provides an in-depth analysis of the major leukemia indications including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML) and chronic myelocytic leukemia (CML). The report examines the global leukemia diseases treatment usage patterns. In addition, the geographical distribution of leukemia therapeutics and markets across the US, the top five countries of Europe and in Japan are provided in the report.

1. Category : Healthcare , Therapeutic
www.MarketResearchReports.com

2. Introduction to Report
 Launch Date: 1st November, 2012
 Number of Pages: 145
 Geography Coverage: Global
 Available Format: PDF
 Price For Single User License: USD 3,500
 Price For Global User License: USD 7,000
 Price For Global User License: USD 10,500
 Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com

3. Report Facts:
In 2011, the leukemia therapeutics market for four
major leukemia indications was estimated at $4.0 billion
 indicating a compound annual growth rate (CAGR) of
21.0% since 2004
Market to grow at a CAGR of 9.5% between 2011 and
2018 to reach to $7.6 billion by 2018
 The US was the leading market with an estimated
sales value of $1.8 billion in 2011 and an approximate
share of 44.3%
The US market is expected to grow at a CAGR of 10.0%
between 2011 and 2018 to record sales value of $3.5
billion in 2018
www.MarketResearchReports.com

4. Report Facts Continued:
The top five countries of Europe together contributed
to sales worth $1.5 billion in 2011 approximate share of
37.9%
The top five countries of Europe are expected to record
sales worth $3.1 billion by the year 2018, at a CAGR of
10.3%.
Japan, in 2011, contributed $720m to the global market
increasing at a CAGR of 20.8% from 2004. It accounts
for an approximate share of 17.8%.
 Growing at a CAGR of 6.1% between 2011 and 2018,
the market is expected to record sales worth $1.1 billion
by 2018.
www.MarketResearchReports.com

5. Scope of the Report :
Data and analysis on the leukemia therapeutics market
in the leading geographies of the world – the US, Japan,
the UK, Germany, France, Italy and Spain
Annualized market data for the leukemia therapeutics
market from 2004 to 2011, with forecasts to 2018
Market data on the geographical landscape and
therapeutic landscape.
Key drivers and restraints that have had a significant
impact on the market
Key M&A activities and licensing agreements that took
place in 2009 and 2011 in the leukemia therapeutics
market.
www.MarketResearchReports.com

6. Reason to Buy:
Data and analysis on the leukemia therapeutics market
in the leading geographies of Align your product
portfolio to the markets with high growth potential.
Build effective strategies to launch their pipeline
products by identifying potential geographies.
Develop key strategic initiatives by studying the key
strategies of top competitors.
Develop market-entry and market expansion strategies
by identifying the geographic markets poised for strong
growth.
Reinforce R&D pipelines by identifying new target
mechanisms which can produce first-in-class molecules
which are safer and more efficacious.
www.MarketResearchReports.com

7. Report Coverage:
Leukemia Market to 2018 - Introduction
Leukemia Market to 2018 - Market Overview
Leukemia Market to 2018 - Geographical Landscape
Leukemia Market to 2018 - Therapeutic Landscape
Leukemia Market to 2018 - Pipeline Analysis
Leukemia Market to 2018 - Competitive Landscape
Leukemia Market to 2018 - Strategic Consolidations
www.MarketResearchReports.com

8. Companies Covered:
1. Novartis AG
2. GlaxoSmithKline plc (GSK)
3. Genzyme Corporation
4. Bristol-Myers Squibb Company (BMS)
5. Eisai Co., Ltd.
www.MarketResearchReports.com

9. How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://www.marketresearchreports.com/gbi-
research/leukemia-therapeutics-market-2018-strong-
late-stage-pipeline-sustain-branded-drugs
About Market Research Reports
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +91-8762746600
www.MarketResearchReports.com